{ "docId": "019de517-75a1-7387-968b-d0dc513bf421", "docSlug": "e930bfcc8684afb6f5a4dd5442b5166d", "documentTitle": "Ocuphire Pharma | Investor Presentation Deck | 42 slides", "authorId": "ocuphire-pharma", "authorName": "Ocuphire Pharma", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 8, "pageCount": 42, "prevPage": 7, "nextPage": 9, "slideType": "problem_statement", "function": "frame_problem", "density": "overcrowded", "nDataPoints": 4, "notes": null, "elementsJson": null, "metadataConfidence": 0.9, "imagePath": null, "slideHref": "/slides/019de517-75a1-7387-968b-d0dc513bf421/8", "deckHref": "/decks/019de517-75a1-7387-968b-d0dc513bf421", "deckJsonHref": "/decks/019de517-75a1-7387-968b-d0dc513bf421.json", "deckAnchorHref": "/decks/019de517-75a1-7387-968b-d0dc513bf421#slide-8", "components": [ { "bbox": { "h": 0.11, "w": 0.07, "x": 0.505, "y": 0.56 }, "kind": "image", "text": null, "attrs": null, "subkind": "illustration", "toolName": null, "toolSlug": null, "confidence": null, "componentId": "14a363f4-918b-486c-8cd4-4f4f67e34c1b", "frameworkName": null, "frameworkSlug": null }, { "bbox": { "h": 0.21, "w": 0.16, "x": 0.57, "y": 0.255 }, "kind": "image", "text": null, "attrs": null, "subkind": "illustration", "toolName": null, "toolSlug": null, "confidence": null, "componentId": "26bfce0b-961b-4015-9144-b47c26dce5af", "frameworkName": null, "frameworkSlug": null }, { "bbox": { "h": 0.11, "w": 0.11, "x": 0.18, "y": 0.56 }, "kind": "image", "text": null, "attrs": null, "subkind": "illustration", "toolName": null, "toolSlug": null, "confidence": null, "componentId": "48b5456c-60d8-4618-81e3-2fc03caa2c3a", "frameworkName": null, "frameworkSlug": null }, { "bbox": { "h": 0.099, "w": 0.128, "x": 0.359, "y": 0.37 }, "kind": "image", "text": null, "attrs": null, "subkind": "illustration", "toolName": null, "toolSlug": null, "confidence": null, "componentId": "591595db-1092-4813-9938-0cb130017830", "frameworkName": null, "frameworkSlug": null }, { "bbox": { "h": 0.1, "w": 0.15, "x": 0.74, "y": 0.72 }, "kind": "image", "text": null, "attrs": null, "subkind": "illustration", "toolName": null, "toolSlug": null, "confidence": null, "componentId": "cb1187d9-db8a-4999-bb4a-6cdfbbe82570", "frameworkName": null, "frameworkSlug": null }, { "bbox": { "h": 0.159, "w": 0.19, "x": 0.077, "y": 0.248 }, "kind": "image", "text": null, "attrs": null, "subkind": "map", "toolName": null, "toolSlug": null, "confidence": null, "componentId": "33253c35-16a8-4cf7-9369-076d24d26b2c", "frameworkName": null, "frameworkSlug": null }, { "bbox": { "h": 0.06, "w": 0.23, "x": 0.12, "y": 0.734 }, "kind": "list", "text": "Physicians have no non-invasive options for NPDR with current standard being wait-and-monitor", "attrs": null, "subkind": "bullet", "toolName": null, "toolSlug": null, "confidence": null, "componentId": "139bbce8-2740-4f73-8442-7e9a6bc0441f", "frameworkName": null, "frameworkSlug": null }, { "bbox": { "h": 0.08, "w": 0.21, "x": 0.757, "y": 0.255 }, "kind": "list", "text": "DR is the leading cause of blindness among working-age adults with the median age of onset at 45 – 50 years", "attrs": null, "subkind": "bullet", "toolName": null, "toolSlug": null, "confidence": null, "componentId": "53e9e4e2-34b4-405f-ba84-ff383cbeba1c", "frameworkName": null, "frameworkSlug": null }, { "bbox": { "h": 0.08, "w": 0.28, "x": 0.69, "y": 0.57 }, "kind": "list", "text": "Majority of moderate to severe patients with DR are not treated with anti-VEGF due to injection burden and no benefit to visual acuity", "attrs": null, "subkind": "bullet", "toolName": null, "toolSlug": null, "confidence": null, "componentId": "69ca6262-ddc8-4412-81c6-defdaf999c0b", "frameworkName": null, "frameworkSlug": null }, { "bbox": { "h": 0.08, "w": 0.26, "x": 0.39, "y": 0.734 }, "kind": "list", "text": "Prevention of Progression is favored by payors with chronic diseases such as diabetes which is the primary driver of increased healthcare costs", "attrs": null, "subkind": "bullet", "toolName": null, "toolSlug": null, "confidence": null, "componentId": "8afdc00b-bf11-4c64-aab0-8d2655cd1c17", "frameworkName": null, "frameworkSlug": null }, { "bbox": { "h": 0.06, "w": 0.21, "x": 0.318, "y": 0.23 }, "kind": "list", "text": "The number of people with DR expected to increase more than 14M by 2050", "attrs": null, "subkind": "bullet", "toolName": null, "toolSlug": null, "confidence": null, "componentId": "ca9bcc30-3c1a-4854-a67b-95a3ccaaeeb3", "frameworkName": null, "frameworkSlug": null }, { "bbox": { "h": 0.04, "w": 0.19, "x": 0.077, "y": 0.439 }, "kind": "list", "text": "There are ~8M adults in the U.S. with NPDR", "attrs": null, "subkind": "bullet", "toolName": null, "toolSlug": null, "confidence": null, "componentId": "f83ec18e-3b2f-4ee7-8cc9-69b101f2a896", "frameworkName": null, "frameworkSlug": null }, { "bbox": { "h": 0.07, "w": 0.82, "x": 0.048, "y": 0.897 }, "kind": "source-note", "text": "American Diabetes Association; International Diabetes Federation; Healthline; *Ocuphire internal analysis and assumptions\nDas UN. DME, retinopathy and age-related macular degeneration as inflammatory conditions. Arch Med Sci. 2016;12(5):1142-1157. doi:10.5114/aoms.2016.61918\nPatient survey adapted from Lions International Foundation and International Diabetes Foundation-Europe; Meltzer 2000\nGuidehouse Triangulation of Global Data, Market Scope and Investor Forecasts (2020) AMD = Age-Related Macular Degeneration; DME = Diabetic Macular Edema; BRVO = Branch Retinal Vein Occlusion\nNational Center for Chronic Disease Prevention & Health Promotion. Health & economic costs of chronic diseases. Atlanta (GA): Centers for Disease Control & Prevention, US Department of Health and Human Services; 2018\nFour-Year Visual Outcomes in a Randomized Trial of Intravitreous Aflibercept for Prevention of Vision Threatening Complications of Diabetic Retinopathy (Protocol W).\" JAMA. February 7, 2023", "attrs": null, "subkind": null, "toolName": null, "toolSlug": null, "confidence": null, "componentId": "955a6307-6628-47af-b028-f341a5385c02", "frameworkName": null, "frameworkSlug": null }, { "bbox": { "h": 0.02, "w": 0.629, "x": 0.048, "y": 0.099 }, "kind": "title", "text": "Current Treatment Landscape Demonstrates Need for Non-Invasive Therapies", "attrs": null, "subkind": "action-title", "toolName": null, "toolSlug": null, "confidence": null, "componentId": "66ee3c8c-666c-4084-b2fa-211452d1c329", "frameworkName": null, "frameworkSlug": null }, { "bbox": { "h": 0.026, "w": 0.369, "x": 0.048, "y": 0.066 }, "kind": "title", "text": "Diabetic Retinopathy at a Glance", "attrs": null, "subkind": "headline", "toolName": null, "toolSlug": null, "confidence": null, "componentId": "cd41fc65-5546-4920-ac85-16eab8fb00fe", "frameworkName": null, "frameworkSlug": null } ], "metrics": [], "tools": [], "frameworks": [], "arcBeats": [ { "to": 10, "from": 6, "beatId": "102a927b-90d9-4296-a592-fca699191176", "arcName": "The Consultant's Gambit", "arcSlug": "consultants-gambit", "beatName": "Problem & Complication", "beatSlug": "consultants-gambit-problem-complication", "evidence": "Slides 6-10 describe the Diabetic Retinopathy market and unmet need", "position": 1, "confidence": 0.8, "parentBeatName": "Complication", "parentBeatSlug": "complication" } ], "loops": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }